Marques-Vidal P - Search Results

1

Pulse Wave Amplitude Drops Index: A Biomarker of Cardiovascular Risk in Obstructive Sleep Apnea.

Solelhac G, Sánchez-de-la-Torre M, Blanchard M, Berger M, Hirotsu C, Imler T, Sánchez-de-la-Torre A, Haba-Rubio J, Marchi NA, Bayon V, Bailly S, Goupil F, Waeber A, Heiniger G, Pigeanne T, Gracia-Lavedan E, Zapater A, Abad J, Ordax E, Masdeu MJ, Cabriada-Nuño V, Egea C, Van Den Broecke S, Vollenweider P, Marques-Vidal P, Vaucher J, Bernardi G, Betta M, Siclari F, Barbé F, Gagnadoux F, Heinzer R. Solelhac G, et al. Am J Respir Crit Care Med. 2023 Jun 15;207(12):1620-1632. doi: 10.1164/rccm.202206-1223OC. Am J Respir Crit Care Med. 2023. PMID: 37017487 Free PMC article.

2

Prevalence of normal weight obesity in Switzerland: effect of various definitions.

Marques-Vidal P, Pécoud A, Hayoz D, Paccaud F, Mooser V, Waeber G, Vollenweider P. Marques-Vidal P, et al. Eur J Nutr. 2008 Aug;47(5):251-7. doi: 10.1007/s00394-008-0719-6. Epub 2008 Jul 5. Eur J Nutr. 2008. PMID: 18604623

3

Predictive accuracy and usefulness of calibration of the ESC SCORE in Switzerland.

Marques-Vidal P, Rodondi N, Bochud M, Pécoud A, Hayoz D, Paccaud F, Mooser V, Waeber G, Vollenweider P. Marques-Vidal P, et al. Eur J Cardiovasc Prev Rehabil. 2008 Aug;15(4):402-8. doi: 10.1097/HJR.0b013e3282fb040f. Eur J Cardiovasc Prev Rehabil. 2008. PMID: 18677163

4

Prevalence of obesity and abdominal obesity in the Lausanne population.

Marques-Vidal P, Bochud M, Mooser V, Paccaud F, Waeber G, Vollenweider P. Marques-Vidal P, et al. BMC Public Health. 2008 Sep 24;8:330. doi: 10.1186/1471-2458-8-330. BMC Public Health. 2008. PMID: 18816372 Free PMC article.

5

Smoking offsets the metabolic benefits of parental longevity in women: the CoLaus study.

Jaunin J, Bochud M, Marques-Vidal P, Vollenweider P, Waeber G, Mooser V, Paccaud F. Jaunin J, et al. Prev Med. 2009 Mar;48(3):224-31. doi: 10.1016/j.ypmed.2008.12.007. Epub 2008 Dec 24. Prev Med. 2009. PMID: 19138704 Free article.

6

Alcohol drinking and cardiovascular risk in a population with high mean alcohol consumption.

Foerster M, Marques-Vidal P, Gmel G, Daeppen JB, Cornuz J, Hayoz D, Pécoud A, Mooser V, Waeber G, Vollenweider P, Paccaud F, Rodondi N. Foerster M, et al. Am J Cardiol. 2009 Feb 1;103(3):361-8. doi: 10.1016/j.amjcard.2008.09.089. Epub 2008 Nov 17. Am J Cardiol. 2009. PMID: 19166690 Free article.

7

[Association between alcohol consumption and cardiovascular risk factors: a narrative review].

Foerster M, Marques-Vidal P, Waeber G, Vollenweider P, Rodondi N. Foerster M, et al. Rev Med Suisse. 2010 Mar 10;6(239):505-6, 508-9. Rev Med Suisse. 2010. PMID: 20373697 Review. French.

8

Prevalence, treatment and control of dyslipidaemia in Switzerland: still a long way to go.

Firmann M, Marques-Vidal P, Paccaud F, Mooser V, Rodondi N, Waeber G, Vollenweider P. Firmann M, et al. Eur J Cardiovasc Prev Rehabil. 2010 Dec;17(6):682-7. doi: 10.1097/HJR.0b013e32833a09ab. Eur J Cardiovasc Prev Rehabil. 2010. PMID: 20700055

9

Use of a Mendelian randomization approach to assess the causal relation of gamma-Glutamyltransferase with blood pressure and serum insulin levels.

Conen D, Vollenweider P, Rousson V, Marques-Vidal P, Paccaud F, Waeber G, Bochud M. Conen D, et al. Am J Epidemiol. 2010 Dec 15;172(12):1431-41. doi: 10.1093/aje/kwq308. Epub 2010 Nov 2. Am J Epidemiol. 2010. PMID: 21044991

10

Statins for cardiovascular prevention according to different strategies: a cost analysis.

Ito MK, Nanchen D, Rodondi N, Paccaud F, Waeber G, Vollenweider P, Marques-Vidal P. Ito MK, et al. Am J Cardiovasc Drugs. 2011;11(1):33-44. doi: 10.2165/11586760-000000000-00000. Am J Cardiovasc Drugs. 2011. PMID: 21265581

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

670 results

Search Page